Patient-Centric Formulations: Strategies for Differentiated Oral Drugs

Life Sciences, Pharmaceutical, Drug Discovery & Development,
  • Thursday, October 29, 2020

While advancements in drug delivery are continually improving drug efficacy and bioavailability, there is still a significant unmet need in terms of developing formulations that make patients’ lives easier. Patient-centricity is not only about best supporting the end user – it’s also about differentiating your product in a sea of oral drug formulations, particularly when looking to file a generic or 505(b)(2) application. This webinar will discuss some key challenges of oral drug formulations, including the swallowability of tablets, bitter taste, and the inconvenience of multiple doses. The team at Lubrizol Life Science Health (LLS Health) will then uncover strategies for overcoming these challenges which will also help differentiate your product, such as with extended drug release, taste masking, and tablet size reduction.


Gaurab Sengupta, Lubrizol

Gaurab Sengupta, Global Business Manager (Pharmaceutical Excipients), Lubrizol Life Science Health

Gaurab Sengupta serves as the Global Business Manager (Pharmaceutical Excipients) for Lubrizol Life Science Health. A Chemical Technologist & MBA by qualification, Sengupta has several years of global cross-functional experience in the pharmaceutical industry across multiple businesses (APIs, CDMO, Generic BD & Licensing, and Excipients). Sengupta is currently responsible for leading Lubrizol Life Science Health’s Pharmaceutical Excipients division (including the market segments of Oral Care, Oral Treatments, and Topical) globally.

Message Presenter
Rajib Bhattacharjee, Lubrizol

Rajib Bhattacharjee, Global Market Manager (Oral Treatments), Lubrizol Life Science Health

Rajib Bhattacharjee serves as the Global Market Manager (Oral treatments) for Lubrizol Life Science Health. A Chemical Engineer & MBA by qualification Bhattacharjee gained experience building the Personal & Home care business in India for Lubrizol until 2014. Currently, he is responsible for leading Lubrizol Life Science Health’s portfolio into the market segment of Oral Treatments globally.

Message Presenter

Who Should Attend?

Formulators, product managers, business development teams, researchers, and innovators from:

  • Branded and generic pharmaceutical companies
  • Start-ups

What You Will Learn

In this webinar, participants will learn about:

  • Challenges for patients with oral drug formulations, including the swallowability of tablets, the inconvenience of multiple doses, and liquid-specific challenges such as bitter taste and difficult administration
  • Strategies for overcoming patient-centric challenges to successfully differentiate oral drug products
  • Extended drug release, table size reduction, taste masking, and mucoadhesion, among other methods for improving oral drugs

Xtalks Partner

Lubrizol Life Science Health

Lubrizol Life Science Health (LLS Health) specializes in helping clients from idea to execution by offering innovative polymers and excipients, as well as best-in-class contract manufacturing services. LLS Health is one of the world’s largest manufacturer of pharmaceutical grade carbomers, polycarbophil, and thermoplastic polyurethanes (TPU), and has been manufacturing pharmaceutical excipients for more than 35 years. With this longstanding history of polymer proficiency and continued investment in cutting-edge technologies and equipment, we are a sustainable partner prepared to meet your needs and enable the development of patient-centric solutions.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account